2022•Unpublished venueRequires access

Global Regulatory Landscape

Jeffrey S. Barrett

Open publisher page 0 citations

Abstract

In this chapter, the authors review the primary global regulatory authorities representing the economies that drive the industry, describing their current organizational structure and procedural expectations. The reference point for these descriptions and differences in structure or procedure will be the US Food and Drug Administration, the oldest and largest regulatory organization, which is still viewed as the standard-bearer for regulatory science. Other organizations, particularly those that govern the largest populations, are discussed as well, and the authors also review how the collective process works for both drugs and vaccines. The organizations include European Medicines Agency, Pharmaceutical and Medical Device Agency, and National Medical Products Administration. Finally, the authors describe efforts to harmonize regulatory science and make it easier for drug and vaccine developers to coordinate regulatory filings and obtain market access globally.

About this research paper

What this paper is about

In this chapter, the authors review the primary global regulatory authorities representing the economies that drive the industry, describing their current organizational structure and procedural expectations. The reference point for these descriptions and differences in structure or procedure will be the US Food and Drug Administration, the oldest and largest regulatory organization, which is still viewed as the standard-bearer for regulatory science. Other organizations, particularly those that govern the largest populations, are discussed as well, and the authors also review how the collective process works for both drugs and vaccines. The organizations include European Medicines Agency, Pharmaceutical and Medical Device Agency, and National Medical Products Administration. Finally, the authors describe efforts to harmonize regulatory science and make it easier for drug and vaccine developers to coordinate regulatory filings and obtain market access globally.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In this chapter, the authors review the primary global regulatory authorities representing the economies that drive the industry, describing their current organizational structure and procedural expectations. The reference point for these descriptions and differences in structure or procedure will be the US Food and Drug Administration, the oldest and largest regulatory organization, which is still viewed as the standard-bearer for regulatory science. Other organizations, particularly those that govern the largest populations, are discussed as well, and the authors also review how the collective process works for both drugs and vaccines. The organizations include European Medicines Agency, Pharmaceutical and Medical Device Agency, and National Medical Products Administration. Finally, the authors describe efforts to harmonize regulatory science and make it easier for drug and vaccine developers to coordinate regulatory filings and obtain market access globally.

Key concepts: Regulatory science, Regulatory agency, Regulatory authority, Agency (philosophy), Regulatory affairs, Business, Food and drug administration, Process (computing)

Related papers

Back to paper searchBrowse research topicsOriginal source
Global Regulatory Landscape — Research Paper | ScholarLens